A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT02005471 · COMPLETED
Trial details
- NCT number
- NCT02005471
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-17
- Primary completion
- 2017-05-08
- Enrollment
- 389
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.